QRG Capital Management Inc. Purchases 5,416 Shares of Sabra Healthcare REIT, Inc. $SBRA

QRG Capital Management Inc. boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,212 shares of the real estate investment trust’s stock after purchasing an additional 5,416 shares during the period. QRG Capital Management Inc.’s holdings in Sabra Healthcare REIT were worth $1,221,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. SVB Wealth LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $34,000. UMB Bank n.a. grew its stake in Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $38,000. Northwestern Mutual Wealth Management Co. grew its stake in Sabra Healthcare REIT by 61.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after acquiring an additional 1,065 shares in the last quarter. Finally, Anchor Investment Management LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $58,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Down 0.2%

NASDAQ:SBRA opened at $17.98 on Thursday. The firm has a market capitalization of $4.31 billion, a P/E ratio of 23.66, a PEG ratio of 1.21 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company’s fifty day moving average price is $18.77 and its 200-day moving average price is $18.16. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.7%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on SBRA. Scotiabank upped their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price on the stock. Wells Fargo & Company upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. BMO Capital Markets upped their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research note on Monday, August 25th. Finally, Truist Financial upped their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research note on Tuesday, September 2nd. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and an average target price of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.